Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
ALCAM and CD6 - multiple sclerosis risk factors.
The treatment of neuromyelitis optica.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Coenzyme Q10 supplementation and multiple sclerosis.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
The amyloid state of proteins in human diseases.
Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
Quality of life and cognitive functions in early onset multiple sclerosis.
Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.
Erratum.
Programmed Death Ligand-1 on Microglia Regulates Th1 Differentiation via Nitric Oxide in Experimental Autoimmune Encephalomyelitis.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
T cell-activation in neuromyelitis optica lesions plays a role in their formation.
Multiple Sclerosis and Antibodies against KIR4.1.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.
Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
Pages
« first
‹ previous
…
533
534
535
536
537
538
539
540
541
…
next ›
last »